IP Library Granted Patent US 8,940,696
Granted Patent B2
US 8,940,696 · App. 14/063,792 · Granted Jan 27, 2015

Methods for prevention and treatment of acute renal injury

Inventors: Hazel H. Szeto (New York, NY); Diane Felsen (Brooklyn, NY)
Assignee: Cornell University
A61K38/07A61K38/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,696
App. No.
14/063,792
Granted
Jan 27, 2015
Kind
B2
Abstract

The disclosure relates to a method for protecting a kidney from renal injury. For example, acute renal injury may be associated with decreased or blocked blood flow in the subject's kidney or exposure to a nephrotoxic agent, such as a radiocontrast dye. The methods include administering to the subject an effective amount of an aromatic-cationic peptide to a subject in need thereof.

Claims (11)

1. A method for protecting a kidney from contrast-induced nephropathy in a subject in need thereof, the method comprising administering to the subject an effective amount of a peptide selected from the group consisting of Phe-D-Arg-Phe-Lys-NH 2 and D-Arg-2′6′Dmt-Lys-Phe-NH 2 .

2. The method of claim 1 , wherein the peptide is Phe-D-Arg-Phe-Lys-NH 2 .

3. The method of claim 1 , wherein the peptide is D-Arg-2′6′Dmt-Lys-Phe-NH 2 .

4. The method of claim 1 , wherein the contrast-induced nephropathy comprises an inflammatory response.

5. The method of claim 1 , wherein the contrast-induced nephropathy comprises a decrease in glomerular filtration rate (GFR) compared to a healthy control subject.

6. The method of claim 1 , wherein the contrast-induced nephropathy comprises a decrease in urinary output compared to a healthy control subject.

7. The method of claim 1 , wherein the contrast-induced nephropathy comprises an increase in renal tubular apoptosis compared to a healthy control subject.

8. The method of claim 1 , wherein the contrast-induced nephropathy comprises loss of renal tubular brush border and/or renal vacuolization.

9. The method of claim 1 , wherein the contrast-induced nephropathy comprises increased serum Cystatin C levels and/or serum creatinine levels compared to a healthy control subject.

10. The method of claim 1 , wherein the contrast-induced nephropathy comprises proteinuria and/or increased urinary creatinine levels compared to a healthy control subject.

11. The method of claim 1 , wherein the peptide is administered prior to or simultaneous with a radiocontrast dye.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2013
From: SZETO, HAZEL; FELSEN, DIANE
To: CORNELL UNIVERSITY
Reel/Frame 031705/0843 →
Continuity (4)
Continuation 13402620 · Feb 22, 2012
Continuation 12392565 · Feb 25, 2009
Provisional Application 61031585 · Feb 26, 2008
Related Publication 20140107033A1 · Apr 17, 2014